DBT-BET merged into CSIR-UGC NET: biotech students face one combined paper from December
Representative image: Kost9n4 / Pixabay
From December 2026, DBT-BET is merged into the Joint CSIR-UGC NET as one Life Sciences and Biotechnology paper; registration closes November 5, 2026.
What Happened
The National Testing Agency (NTA) has folded the Department of Biotechnology's separate eligibility test, DBT-BET, into the Joint CSIR-UGC NET, starting with the December 2026 exam. Biology students will now sit a single combined paper called Life Sciences and Biotechnology (LS and BT) to compete for research fellowships from both the Council of Scientific and Industrial Research (CSIR) and the Department of Biotechnology (DBT). The change came with the December 2026 notification, under which registration opened on October 7, 2026 and closes on November 5, 2026. According to reports on the notice, the exam is to be held as a computer-based test on December 19, 22 and 27, 2026.
Key Facts
- From the December 2026 cycle, DBT-BET no longer runs as a separate exam; it is merged into the Joint CSIR-UGC NET.
- A new combined subject, Life Sciences and Biotechnology, replaces separate routes for life science and biotechnology candidates.
- CSIR and DBT have agreed to award fellowships in both fields through the joint exam; DBT-funded fellowships stay with DBT, and CSIR carries no financial liability for them.
- Candidates who qualify in biotechnology become eligible for Junior Research Fellowship (JRF), Assistant Professor and PhD admission categories.
- Registration runs from October 7 to November 5, 2026, with a late window from November 6 to 9 (extra fee of Rs 500) and corrections from November 10 to 12.
- Most reports give the exam dates as December 19, 22 and 27, 2026, in two shifts; candidates should confirm on the official NTA site.
Why It Matters
For a student finishing an MSc in biotechnology, microbiology or a related life science, the research-fellowship path used to mean two separate exams with two syllabuses, two fees and two calendars. DBT-BET was the gateway to DBT's junior research fellowships, while the CSIR-UGC NET in Life Sciences opened CSIR fellowships, lecturer eligibility and PhD admission. Merging them means one application, one paper and one result that is read by both funding bodies.
There are trade-offs. A single exam is one shot instead of two in a cycle, so a bad day carries more weight. Biotechnology students who were used to a paper built around their own subject will now compete in a broader life sciences and biotechnology format, and those from pure biology backgrounds will face more biotechnology content. Reports on the merger describe a revised syllabus and exam pattern, which makes the official information bulletin the first thing any candidate should read before choosing study material.
The money side is spelled out. Fellowships funded by DBT continue to be paid and managed by DBT, and CSIR takes on no financial liability for them. That matters because students often worry that a merger means fewer funded seats. The notice, as reported, does not cut DBT's role; it changes how candidates are selected.
For students, the decision is about timing. The exam is in December, and the application window closes on November 5, so anyone who was planning for a separate DBT-BET date needs to reset their plan now.
| Before December 2026 | From December 2026 |
|---|---|
| DBT-BET, a separate exam for DBT fellowships | No separate DBT-BET |
| CSIR-UGC NET Life Sciences for CSIR fellowships | One combined Life Sciences and Biotechnology paper |
| Two applications and two fees | One application through NTA |
| Separate results | One result used by CSIR and DBT |
Impact
Short-term: Biotechnology and life science graduates must register for the Joint CSIR-UGC NET by November 5, 2026 to compete for DBT fellowships this cycle, and should prepare for the combined paper.
Long-term: A single national route into life science research could simplify selection and reduce costs for students, while making the one December or June exam more decisive for each candidate.
Who is affected: MSc and final-year students in life sciences and biotechnology, aspirants for JRF and assistant professor posts, PhD applicants, coaching providers, and universities and labs that recruit research fellows.
Key Takeaway
DBT-BET is gone as a separate test: from December 2026, biotechnology and life science fellowships from both CSIR and DBT are decided through one combined paper in the Joint CSIR-UGC NET.
Questions and Answers
Is DBT-BET being held separately in 2026-27?
No. From the December 2026 cycle it has been merged into the Joint CSIR-UGC NET as part of a combined Life Sciences and Biotechnology paper.
Will DBT still give fellowships?
Yes. CSIR and DBT have agreed to award fellowships through the joint exam, and DBT-funded fellowships will continue to be administered by DBT.
What is the last date to apply for CSIR-UGC NET December 2026?
The regular window closes on November 5, 2026. A late window with an extra Rs 500 fee runs from November 6 to 9, and corrections are allowed from November 10 to 12.
What should a biotechnology student do first?
Download the official information bulletin from the NTA's CSIR NET site, check the revised syllabus for the combined paper and confirm the exam dates before planning preparation.
Disclaimer: Prepared by the Peepals newsroom from publicly available sources with AI assistance. Information is accurate to the best of our knowledge at the time of publication and may change. Images may be representative. Not professional advice. Report an error via our contact page.
Sourced and fact-checked by the Peepals Global Editorial Team
Reported, fact-checked and published by the Peepals Global Editorial Team.
